The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Gareev I.F.

Bashkir State Medical University of the Ministry of Health of the Russia, Ufa, Russia

Novikova L.B.

Bol'nitsa skoroĭ meditsinskoĭ pomoshchi, Ufa

Beylerli O.A.

Bashkir State Medical University of the Ministry of Health of the Russia, Ufa, Russia

Circulating microrPas as new potential biomarkers for the diagnosis of high-grade gliomas

Authors:

Gareev I.F., Novikova L.B., Beylerli O.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(5): 86‑90

DOI: 10.17116/jnevro201911905186

Read: 979 times

Download PDF (RU)
Contact the author
Table of contents

CIRCULATING MICRORPAS AS NEW POTENTIAL BIOMARKERS FOR THE DIAGNOSIS OF HIGH-GRADE GLIOMAS
CIRCULATING MICRORPAS AS NEW POTENTIAL BIOMARKERS FOR THE DIAGNOSIS OF HIGH-GRADE GLIOMAS

To cite this article:

Gareev IF, Novikova LB, Beylerli OA. Circulating microrPas as new potential biomarkers for the diagnosis of high-grade gliomas. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(5):86‑90. (In Russ.)
https://doi.org/10.17116/jnevro201911905186

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The influence of demo­graphic factors and major como­rbidities on serum circulating regu­latory microRNAs in patients with coro­nary artery athe­rosclerosis and thoracic aortic aneurysm: a single-center cohort study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):174-182
Radiation therapy with focal dose esca­lation in the treatment of glioblastoma. P.A. Herzen Journal of Onco­logy. 2025;(2):64-69
Serum expression of microRNA-21, microRNA-125a, microRNA-125b, microRNA-214 in coro­nary artery disease patients. Russian Cardiology Bulletin. 2025;(2):13-19
Glymphatic system in health and disease: a narrative review. Burdenko's Journal of Neurosurgery. 2025;(4):112-118
Extracellular vesi­cles and their role in endo­metrial rece­ptivity in patients with recu­rrent implantation failure. Russian Journal of Human Reproduction. 2025;(4):46-52
Machine learning models for brain tumors differential diagnosis. Russian Journal of Preventive Medi­cine. 2025;(9):87-93
TERTp muta­tion screening using digi­tal droplet PCR of collection of 52 paired DNA samples from blood plasma and tumor tissue in patients with glioblastoma. Burdenko's Journal of Neurosurgery. 2025;(5):87-95
Fluorescence navi­gation and endo­scopic assi­stance in surgery for brain glioblastomas. Burdenko's Journal of Neurosurgery. 2025;(6):28-37
Surgery for gliomas of Broca’s area. Burdenko's Journal of Neurosurgery. 2025;(6):38-45
Possibilities of inte­ractions of circular RNAS with nucleic acids and proteins. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(4-2):28-32
Abstract:

High-grade glial tumors (also called high-grade gliomas) are the most aggressive primary brain neoplasms. Therefore, much attention is paid to understanding the pathogenesis, as well as to the development of new effective diagnostic and therapeutic methods. MicroRNAs are short non-coding RNAs, 18—22 nucleotides in length, which, as has already been shown, play a direct role in carcinogenesis. Circulating miRNAs are released into the extracellular space and can be in a stable state for a long time in most biological liquids, including blood serum and plasma. Circulating miRNAs are promising biomarkers with different expression profiles specific for various human disorders, including cancer diseases.There are many data showing that different profiles of circulating miRNAs, in particular in extracellular vesicles (EV), in human biological fluids are associated with numerous neoplastic processes, which indicates that miRNAs can be a truly new class of biomarkers for early diagnosis and prognosis of high-grade gliomas.

Keywords:

microRNAs
circulating
biological fluids
marker
glioma
glioblastoma

Authors:

Gareev I.F.

Bashkir State Medical University of the Ministry of Health of the Russia, Ufa, Russia

Novikova L.B.

Bol'nitsa skoroĭ meditsinskoĭ pomoshchi, Ufa

Beylerli O.A.

Bashkir State Medical University of the Ministry of Health of the Russia, Ufa, Russia

Close metadata

References:

  1. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol. 2006;2:494-503. https://doi.org/10.1038/ncpneuro0289
  2. Mutter N, Stupp R. Temozolomide: a milestone in neurooncology and beyond? Expert Rev Anticancer Ther. 2006;6:1187-204. https://doi.org/10.1586/14737140.6.8.1187
  3. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-Year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459-466. https://doi.org/10.1016/S1470-2045(09)70025-7
  4. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9:453-461. https://doi.org/10.1016/S1470-2045(08)70125-6
  5. MacLellan SA, MacAulay C, Lam S, Garnis C. Pre-profiling factors influencing serum microRNA levels. BMC Clin Pathol. 2014;14:27-38. https://doi.org/10.1186/1472-6890-14-27
  6. Roth P, Wischhusen J, Happold C, Chandran PA, Hofer S, Eisele G, Weller M, Keller A. A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem. 2011;118:449-457. https://doi.org/10.1111/j.1471-4159.2011.07307.x
  7. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131:803-820. https://doi.org/10.1007/s00401-016-1545-1
  8. Areeb Z, Stylli SS, Koldej R, Ritchie DS, Siegal T, Morokoff AP, Kaye AH, Luwor RB. MicroRNA as potential biomarkers in Glioblastoma. J Neurooncol. 2015;125:237-248. https://doi.org/10.1007/s11060-015-1912-0
  9. Ye X, Wei W, Zhang Z, He C, Yang R, Zhang J, Wu Z, Huang Q, Jiang Q. Identification of microRNAs associated with glioma diagnosis and prognosis. Oncotarget. 2017;8:26394-26403. https://doi.org/10.18632/oncotarget.14445
  10. Westphal M, Lamszus K. Circulating biomarkers for gliomas. Nat Rev Neurol. 2015;11:556-566. https://doi.org/10.1038/nrneurol.2015.171
  11. He Y, Lin J, Kong D, Huang M, Xu C, Kim TK, Etheridge A, Luo Y, Ding Y, Wang K. Current State of Circulating MicroRNAs as Cancer Biomarkers. Clin Chem. 2015;61:1138-1155. https://doi.org/10.1373/clinchem.2015.241190
  12. Chevillet JR, Lee J, Briggs HA, He Y, Wang K. Issues and Prospects of microRNA-Based Biomarkers in Blood and Other Body Fluids. Molecules. 2014;19:6080-6105. https://doi.org/10.3390/molecules19056080
  13. Kosaka N, Yoshioka Y, Fujita Y, Ochiya T. Versatile roles of extracellular vesicles in cancer. J Clin Invest. 2016;126:1163-1172. https://doi.org/10.1172/JCI81130
  14. Kalluri R. The biology and function of exosomes in cancer. J Clin Invest. 2016;126:1208-1215. https://doi.org/10.1172/JCI81135
  15. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky AM, Breakefield XO. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470-1476. https://doi.org/10.1038/ncb1800
  16. Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, Pérez-Hernández D, Vázquez J, Martin-Cofreces N, Martinez-Herrera DJ, Pascual-Montano A, Mittelbrunn M, Sánchez-Madrid F. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4:2980-2990. https://doi.org/10.1038/ncomms3980
  17. Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas. J Exp Clin Cancer Res. 2016;35:124-135. https://doi.org/10.1186/s13046-016-0393-0
  18. Figueroa JM, Carter BS. Detection of glioblastoma in biofluids. J Neurosurg. 2018;129(2):334-340. https://doi.org/10.3171/2017.3.JNS162280.19
  19. Siegal T, Charbit H, Paldor I, Zelikovitch B, Canello T, Benis A, Wong ML, Morokoff AP, Kaye AH, Lavon I. Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab. J Neurosurg. 2016;125:1008-1015. https://doi.org/10.3171/2015.8.JNS15437
  20. Tumilson CA, Lea RW, Alder JE, Shaw L. Circulating MicroRNA biomarkers for glioma and predicting response to therapy. Mol Neurobiol. 2014;50:545-558. https://doi.org/10.1007/s12035-014-8679-8
  21. Jia S, Zocco D, Samuels ML, Chou MF, Chammas R, Skog J, Zarovni N, Momen-Heravi F, Kuo WP. Emerging technologies in extracellular vesicle-based molecular diagnostics. Expert Rev Mol Diagn. 2014;14:307-321. https://doi.org/10.1586/14737159.2014.893828
  22. Evans SM, Putt M, Yang XY, Lustig RA, Martinez-Lage M, Williams D, Desai A, Wolf R, Brem S, Koch CJ. Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients. J Neurooncol. 2016;127:391-400. https://doi.org/10.1007/s11060-015-2051-3
  23. Feng YH, Tsao CJ. Emerging role of microRNA-21 in cancer (Review). Biomed Rep. 2016;5:395-402. https://doi.org/10.3892/br.2016.747
  24. Manterola L, Guruceaga E, Perez-Larraya JG, González-Huarriz M, Jauregui P, Tejada S, Diez-Valle R, Segura V, Samprón N, Barrena C, Ruiz I, Agirre A, Ayuso A, Rodríguez J, González A, Xipell E, Matheu A, López de Munain A, Tuñón T, Zazpe I, García-Foncillas J, Paris S, Delattre JY, Alonso MM. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro-Oncol. 2014;16:520-527. PMID: 24435880. https://doi.org/10.1093/neuonc/not218
  25. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39:7223-7233. https://doi.org/10.1093/nar/gkr254
  26. Wang Q, Li P, Li A, Jiang W, Wang H, Wang J, Xie K. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma. J Exp Clin Cancer Res. 2012;31:97-107. https://doi.org/10.1186/1756-9966-31-97
  27. Ivo D’Urso P, Urso OF, Gianfreda CD. MiR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma. Curr Genomics. 2015;16:304-311. https://doi.org/10.2174/1389202916666150707155610
  28. Zhang R, Pang B, Xin T, Guo H, Xing Y, Xu S, Feng B, Liu B, Pang Q. Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma. Mol Neurobiol. 2016;53:1452-1460.
  29. Zhi F, Shao N, Wang R, Deng D, Xue L, Wang Q, Zhang Y, Shi Y, Xia X, Wang S, Lan Q, Yang Y. Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma. Neuro-Oncol. 2015;17:383-391. https://doi.org/10.1093/neuonc/nou169
  30. Lai NS, Wu D, Fang X, Lin YC, Chen SS, Li ZB, Xu SS. Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma. Br J Cancer. 2015;112:1241-1246. https://doi.org/10.1038/bjc.2015.91
  31. Wu J, Li L, Jiang C. Identification and Evaluation of Serum MicroRNA-29 Family for Glioma Screening. Mol Neurobiol. 2015;52:1540-1546. https://doi.org/10.1007/s12035-014-8937-9
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.